Total planned funding: $175,487,142
Allocations
Countries/Regions
India | $175,487,142 |
Organizational Types
NGO | $63,060,170 |
Unknown | $53,253,373 |
Own Agency | $28,408,907 |
University | $16,282,112 |
Private Contractor | $4,098,272 |
Multi-lateral Agency | $3,516,808 |
Implementing Agency | $3,100,000 |
FBO | $1,600,000 |
Host Country Government Agency | $1,540,200 |
Other USG Agency | $627,300 |
Program Areas
Governance and Systems | $80,835,437 |
Prevention | $36,282,803 |
Management and Operations | $21,053,586 |
Care | $17,402,621 |
Treatment | $8,502,714 |
Testing | $6,982,189 |
Budget Codes
OHSS: Health Systems Strengthening | $49,284,572 |
HVSI: Strategic Information | $25,593,283 |
HVMS: Management and Operations | $21,053,586 |
HVOP: Sexual Prevention: Other Sexual Prevention | $20,726,374 |
HBHC: Care: Adult Care and Support | $8,574,539 |
HTXS: Treatment: Adult Treatment | $7,949,219 |
HVCT: Testing: HIV Testing and Counseling | $6,982,189 |
HLAB: Laboratory Infrastructure | $5,957,582 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,681,255 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,425,472 |
HKID: Care: Orphans and Vulnerable Children | $4,442,937 |
HVTB: Care: TB/HIV | $3,561,805 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,140,049 |
HMBL: Biomedical Prevention: Blood Safety | $1,299,653 |
PDCS: Care: Pediatric Care and Support | $823,340 |
PDTX: Treatment: Pediatric Treatment | $530,018 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$52,628,884
Countries/Regions
FHI 360:
$22,479,182
Countries/Regions
USG Aggregated Agencies:
$17,840,840
Countries/Regions
Voluntary Health Services:
$11,460,000
Countries/Regions